Publicaciones en colaboración con investigadores/as de Hospitais da Universidade de Coimbra (47)

2024

  1. Does remission in systemic lupus erythematosus according to the 2021 DORIS definition match the treating rheumatologist's judgement?

    Rheumatology (Oxford, England), Vol. 63, Núm. 1, pp. 72-78

  2. Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time?

    Arthritis Care and Research, Vol. 76, Núm. 1, pp. 88-97

2023

  1. Glucocorticoids prescribing practices in systemic sclerosis: an analysis of the EUSTAR database

    Rheumatology (Oxford, England), Vol. 62, Núm. 4, pp. 1559-1567

2022

  1. Acute leukemia arising from myeloproliferative or myelodysplastic/myeloproliferative neoplasms: A series of 372 patients from the PETHEMA AML registry

    Leukemia Research, Vol. 115

  2. Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma

    Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 28, Núm. 21, pp. 4771-4781

  3. FlowCT for the analysis of large immunophenotypic data sets and biomarker discovery in cancer immunology

    Blood Advances, Vol. 6, Núm. 2, pp. 690-703

  4. ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19

    Scientific Data, Vol. 9, Núm. 1

  5. International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis

    JAMA Dermatology, Vol. 158, Núm. 5, pp. 561-572

  6. Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food—A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paper

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 77, Núm. 6, pp. 1736-1750

  7. Recommendations for the diagnosis and treatment of patients with thrombotic thrombocytopenic purpura

    Medicina Clinica, Vol. 158, Núm. 12, pp. 630.e1-630.e14

2021

  1. Management of anaphylaxis due to COVID-19 vaccines in the elderly

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 10, pp. 2952-2964

  2. Multicentric evaluation of the new HemosIL Acustar® chemiluminescence ADAMTS13 activity assay

    International Journal of Laboratory Hematology, Vol. 43, Núm. 3, pp. 485-493

  3. Multinational evaluation of the BioFire® FilmArray® Pneumonia plus Panel as compared to standard of care testing

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 40, Núm. 8, pp. 1609-1622

  4. Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry

    Respiratory Medicine, Vol. 178

  5. SARS-CoV-2 outbreak in immune-mediated inflammatory diseases: the Euro-COVIMID multicentre cross-sectional study

    The Lancet Rheumatology, Vol. 3, Núm. 7, pp. e481-e488

2020

  1. Evolving the comprehensive management of rheumatoid arthritis: identification of unmet needs and development of practical and educational tools

    Clinical and experimental rheumatology, Vol. 38, Núm. 6, pp. 1056-1067

  2. Non-lymphopenic pneumocystis pneumonia in low-dose methotrexate therapy: An exception to every rule

    Respiratory Medicine Case Reports, Vol. 31

  3. Small Bowel Enteroscopy - A Joint Clinical Guideline from the Spanish and Portuguese Small Bowel Study Groups

    GE Portuguese Journal of Gastroenterology, Vol. 27, Núm. 5, pp. 324-335

2019

  1. 2019 ARIA Care pathways for allergen immunotherapy

    Allergologie, Vol. 42, Núm. 9, pp. 404-425

  2. Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course

    Journal of Clinical Medicine, Vol. 8, Núm. 11